In light of the newly released report by the Centers for Disease Control and Prevention (CDC) about the increase in mortality and morbidity of mesothelioma patients, the Mesothelioma Applied Research Foundation (Meso Foundation), the only nonprofit organization dedicated to eradicating mesothelioma and the suffering caused by this cancer, has released a statement emphasizing the need […]
We are thrilled to announce that our executive director, Mary Hesdorffer, was selected as the recipient of the Gabriella Graham Patient Advocacy Award. This award honors individuals who have dedicated significant time and effort to help patients obtain the best care possible; have increased awareness and provided education of the disease to health care providers; […]
Through partial funding by the Mesothelioma Applied Research Foundation, the National Comprehensive Cancer Network (NCCN) has published updated patient resources for malignant pleural mesothelioma. The resources include the NCCN Guidelines for Patients and NCCN Quick Guide sheet.
The NCCN Guidelines for Patients is based on the guidelines used globally in clinical practice to allow health care […]
The Meso Foundation announced today that at the end of this month, Dr. Lee Krug’s term on the Board of Directors (BOD) of the Mesothelioma Applied Research Foundation will end. Dr. Krug joined the Foundation’s board in 2011, after several years serving on the organization’s Science Advisory Board (SAB). Dr. Krug led the organization as […]
Melissa Culligan, a member of the Mesothelioma Applied Research Foundation’s Board of Directors started her work on Saturday, December 3 at the 17th World Conference on Lung Cancer (WCLC), held in Vienna, Austria by attending an all day working meeting focused on the development of an Immunotherapy Guideline for clinicians. This working meeting was held […]